Rh Type Test

Your Rh type is one of those pieces of health information that barely matters day to day but becomes urgent in two specific situations: pregnancy and blood transfusion. If you are Rh negative and you carry a baby who is Rh positive, your immune system can mount an attack against your baby's blood cells. If you receive a transfusion with the wrong Rh type, your body can destroy the donated blood. In both cases, the consequences range from mild to life-threatening.

About 85% of people are Rh positive, meaning they carry the RhD protein on their red blood cells. The remaining 15% are Rh negative, meaning the protein is absent. Unlike many blood tests, your Rh type is fixed at birth and will never change. A single test tells you your status for life.

What the RhD Protein Actually Is

Rh type is determined by a protein called RhD (Rhesus D), a molecule embedded in the outer membrane of your red blood cells. It is produced by cells in your bone marrow, the tissue inside your bones that manufactures blood cells. The protein is encoded by a gene called RHD, and a nearby gene called RHCE produces related proteins (C, c, E, e) that make up the broader Rh system.

The Rh protein complex appears to function as a transport channel that helps regulate the chemical balance inside red blood cells. When the entire Rh complex is missing (an extremely rare condition), red blood cells become fragile and break down more easily. For most people, though, the practical significance of Rh type comes down to one question: does your immune system see RhD as "self" or "foreign"?

Pregnancy and Rh Incompatibility

The most important clinical scenario involving Rh type is pregnancy. When an Rh negative mother carries an Rh positive baby, small amounts of the baby's blood can cross the placenta and enter the mother's circulation. Her immune system recognizes the RhD protein as foreign and produces antibodies against it. This process is called alloimmunization.

In a first pregnancy, the antibodies usually form too late to cause serious harm. But in subsequent pregnancies with another Rh positive baby, those antibodies are already present. They cross the placenta and attack the baby's red blood cells, causing a condition called hemolytic disease of the fetus and newborn (HDFN), where the baby's red blood cells are broken down faster than they can be replaced. Before modern prevention, HDFN was a major cause of stillbirth and infant death. In Pakistan, where prevention programs are less established, a study of over 1,600 pregnant women found that 17% were Rh negative, and their pregnancies had higher rates of miscarriage, stillbirth, and newborn death.

Prevention relies on a medication called anti-D immunoglobulin (also known as RhIG). Given to Rh negative mothers during and after pregnancy, it neutralizes any fetal Rh positive blood cells before the mother's immune system can react. This treatment is roughly 99% effective and has reduced HDFN-related deaths dramatically. Globally, however, about half of women who need anti-D immunoglobulin do not receive it, leaving hundreds of thousands of pregnancies at risk each year.

Transfusion Safety

Every time blood is transfused, the recipient's Rh type must match the donor's. Giving Rh positive blood to an Rh negative person can trigger antibody formation and, on repeat exposure, a hemolytic transfusion reaction in which the recipient's immune system destroys the donated red blood cells. This is why Rh negative blood is reserved for Rh negative patients whenever possible.

In emergencies when a patient's blood type is unknown, hospitals sometimes use O positive blood (the most common type). A study of 437 emergency patients who received O positive blood without prior typing found that only about 3% to 6% developed anti-D antibodies. While not zero, this rate was considered acceptable given the life-saving need, and the approach preserved scarce O negative units for known Rh negative patients.

For people who receive frequent transfusions, such as those with sickle cell disease or thalassemia, extended Rh matching beyond just the D antigen (a molecule on the cell surface that the immune system can recognize), including the related C, c, E, and e proteins, is recommended to reduce the risk of developing antibodies that complicate future transfusions.

Rh Type and Broader Disease Risk

Beyond pregnancy and transfusion, researchers have looked at whether Rh type influences risk for other diseases. The findings are generally modest and should not cause alarm.

The strongest signal comes from a Swedish study of 5.1 million people, which found that Rh positive individuals had a slightly higher rate of pregnancy-induced hypertension (high blood pressure during pregnancy) compared to Rh negative individuals, with an incidence rate about 12% higher. This was the only Rh association that survived strict statistical correction across hundreds of diseases tested.

Several studies during the COVID-19 pandemic reported that Rh negative individuals had a modestly lower risk of SARS-CoV-2 infection and severe illness. A Canadian study of over 22,500 people found that O negative blood type was associated with a slightly lower risk of both infection and severe COVID-19. A meta-analysis confirmed a pattern of Rh positive status being linked to higher infection odds across multiple viral and non-viral infections, though the effect sizes were small and study quality varied considerably.

One study of 499 heart failure patients who received a cardiac resynchronization device found that Rh negative patients had about 32% better survival than Rh positive patients. This is an intriguing finding but comes from a single study in a very specific clinical population and should not be generalized.

A large umbrella review covering 51 meta-analyses and 270 associations concluded that while ABO and Rh blood groups show statistical links to various conditions, strong, high-certainty evidence was rare. For most diseases, Rh type plays a very small role compared to standard risk factors like age, blood pressure, blood sugar, and smoking.

When Results Can Be Misleading

Rh type is one of the most stable lab results you will ever receive. It does not fluctuate with meals, exercise, stress, medications, or time of day. Once determined, your Rh status is the same for life. No common medication, including statins, metformin, steroids, or thyroid drugs, changes whether you are Rh positive or Rh negative.

The rare exception involves people who have received a recent blood transfusion. If you were transfused with blood from someone of a different Rh type, a standard blood test might temporarily pick up the donor's red blood cells rather than your own. In multi-transfused patients, genetic testing (genotyping) may be needed to confirm true Rh status. Certain genetic variants can also produce a "weak" or "partial" D antigen that may test as negative on routine screening but positive with more sensitive methods. These variants are more common in people of African descent and can be clarified with molecular testing if needed.

How Your Result Is Reported

Unlike most blood tests, Rh type does not come back as a number on a scale. Your result is simply Rh positive (also written as Rh+ or D+) or Rh negative (Rh- or D-). There is no spectrum of values, no optimal range, and no "borderline" zone. This is a binary genetic trait.

Frequencies vary by ethnicity. Rh negative blood is most common among people of European descent (about 15% to 17%) and much less common in East Asian and Sub-Saharan African populations (often under 5%). These population differences do not change the clinical significance of the result.

What to Do With Your Result

If you are Rh positive, your result has limited day-to-day implications. You can receive both Rh positive and Rh negative blood, and your pregnancies are not at risk for Rh-related complications (though ABO incompatibility is a separate issue your provider may screen for).

If you are Rh negative, the result matters most in two contexts. First, if you are pregnant or planning a pregnancy, make sure your care team knows your Rh status so they can provide anti-D immunoglobulin at the right times, typically around 28 weeks of pregnancy and after delivery if the baby is Rh positive. Second, if you ever need a blood transfusion, your medical records should clearly reflect your Rh negative status so you receive compatible blood.

If your result is unclear, described as "weak D" or "inconclusive," ask about molecular genotyping. This DNA-based test can definitively classify your Rh type and is especially useful for women of childbearing age who need to know whether they require anti-D prophylaxis. In the Netherlands, a nationwide program using non-invasive prenatal testing (a blood draw from the mother) to determine fetal Rh type achieved a sensitivity of 99.94% and specificity of 97.74%, allowing targeted prophylaxis only for pregnancies that need it.

Why Knowing Once Is Enough

Because Rh type is genetically determined, a single accurate test establishes your status permanently. There is no reason to retest unless a previous result was questionable (such as a weak D finding that was never followed up with genotyping) or you have been heavily transfused and need confirmation of your native type. If you have never been typed, getting tested now means you have this information available before a situation arises where it matters urgently.